Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
INTELLIGENT BIO SOLUTIONS INC. (GBS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
8-K
| Quarterly results |
| 11/09/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 02/10/2022 |
8-K
| Quarterly results|
Docs:
|
"GBS, INC. PRELIMINARY CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 Revenue: Other income: Government support income $ 177,791 $ 283,037 $ 177,791 $ 338,464 Total revenue 177,791 283,037 177,791 338,464 Operating expenses: General and administrative 1,003,244 671,450 2,335,764 1,192,453 Development and regulatory approval 2,641,182 341,820 2,747,981 372,758 Prospectus and capital raising - 187,093 - 353,574 Total operating expenses 3,644,426 1,200,363 5,083,745 1,918,785 Loss from operations Other income : Interest expense Loss from unconsolidated equity method investment" |
|
| 11/17/2021 |
8-K
| Quarterly results|
Docs:
|
"PRELIMINARY CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three Months Ended September 30, 2021 2020 Revenues: Other income: Government support income $ - $ 55,427 Total revenues - 55,427 Operating expenses: General and administrative expenses 1,332,520 521,003 Development and regulatory approval expenses 106,799 30,938 Prospectus and capital raising expenses - 166,481 Total operating expenses 1,439,319 718,422 Loss from operations Other income : Interest expense - Loss from unconsolidated equity method investment - Realized foreign exchange loss Interest income 4,597 70 Total other income 1,479 Loss before income taxes Income taxes - - Net loss Net loss attributable to non-controlling interest Net loss attributable to GBS, Inc. $ $ Other comprehensive loss, net of tax..." |
|
|
|